Literature DB >> 10374122

Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion.

A B Coumans1, P C Huijgens, C Jakobs, R Schats, J I de Vries, M G van Pampus, G A Dekker.   

Abstract

The objective of this study was to establish whether or not patients with unexplained recurrent abortion have an increased incidence of haemostatic or metabolic abnormalities. Fifty-two patients with a history of unexplained habitual abortion (two or more spontaneous abortions before 16 weeks' gestation) were tested for protein S, protein C and antithrombin (AT) III deficiency, activated protein C (aPC) resistance, hyperhomocysteinaemia and anticardiolipin antibodies (ACA). The control group consisted of 67 healthy women with a history of only uncomplicated pregnancies. Blood samples were taken for measuring protein S, protein C, AT III, ACA and activated protein C resistance and a methionine loading test was performed. Of the 46 patients tested for protein S deficiency, 8 (17.4%) were positive. Of the 43 patients tested, two (4.7%) were protein C deficient and none was AT III deficient. Of the 42 patients tested for ACA, eight (19.1%) had detectable antibodies. Of the 44 patients tested for aPC resistance, two (4.6%) were positive. Finally, 35 patients were tested for hyperhomocysteinaemia and six (17.1%) were positive. It was concluded that parous women with a history of unexplained recurrent abortion have an increased incidence of hyperhomocysteinaemia and a trend of increased incidence of ACA can be found.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10374122     DOI: 10.1093/humrep/14.1.211

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Preconception folate status and reproductive outcomes among a prospective cohort of folate-replete women.

Authors:  Elizabeth A DeVilbiss; Sunni L Mumford; Lindsey A Sjaarda; Matthew T Connell; Keewan Kim; James L Mills; Robert M Silver; Enrique F Schisterman
Journal:  Am J Obstet Gynecol       Date:  2019-02-23       Impact factor: 8.661

2.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 3.  Anticoagulant therapy and pregnancy.

Authors:  Aiko Makino; Mayumi Sugiura-Ogasawara
Journal:  Reprod Med Biol       Date:  2008-02-01

4.  Risk of Recurrent Pregnancy Loss in the Ukrainian Population Using a Combined Effect of Genetic Variants: A Case-Control Study.

Authors:  Eleni M Loizidou; Anastasia Kucherenko; Pavlo Tatarskyy; Sergey Chernushyn; Ganna Livshyts; Roman Gulkovskyi; Iryna Vorobiova; Yurii Antipkin; Oleksandra Gorodna; Marika A Kaakinen; Inga Prokopenko; Ludmila Livshits
Journal:  Genes (Basel)       Date:  2021-01-05       Impact factor: 4.096

5.  Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure.

Authors:  Farhad Khosravi; Saeed Zarei; Negah Ahmadvand; Zahra Akbarzadeh-Pasha; Elham Savadi; Amir-Hassan Zarnani; Mohammad-Reza Sadeghi; Mahmood Jeddi-Tehrani
Journal:  J Assist Reprod Genet       Date:  2013-11-06       Impact factor: 3.412

6.  Association between Nutritional Status with Spontaneous Abortion.

Authors:  Rahimeh Ahmadi; Saeideh Ziaei; Sosan Parsay
Journal:  Int J Fertil Steril       Date:  2016-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.